Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02856594 · ClinicalTrials.gov registry record · Phase 2
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 469
- Enrollment target
NCT02856594: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT02856594 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 469 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02856594, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 469 participants
- Enrollment target
Study Summary
This study aims to determine whether, compared with placebo, the nighttime administration of a intravenous dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in extubated post-cardiac surgical patients.
Interventions
- DRUG Placebo
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 469 participants |
| Start Date | 2017-03-06 |
| Est. Completion | 2022-02-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02856594
The ClinicalTrials.gov registry entry for NCT02856594 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 469 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02856594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02856594 about?
NCT02856594 is a clinical study titled "Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep". This study aims to determine whether, compared with placebo, the nighttime administration of a intravenous dexmedetomidine is effective at inducing sleep and preventing postoperative delirium in extubated post-cardiac surgical patients.
What is the current status of trial NCT02856594?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 469 participants. The study started on 2017-03-06. Estimated completion is 2022-02-16.
What interventions are being tested in trial NCT02856594?
The interventions under investigation include: Placebo (DRUG), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT02856594?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.